Novartis tests new arthritis drug in early human trial

NCT ID NCT07029555

Summary

This early-stage study is testing the safety and how the body processes a new rheumatoid arthritis drug called PIT565. The trial will enroll 57 adults with rheumatoid arthritis who will receive injections of the experimental medication. Researchers will monitor for side effects and measure how the drug moves through the body to determine if it's safe for further testing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    CABA, C1181ACH, Argentina

  • Novartis Investigative Site

    RECRUITING

    Sofia, 1618, Bulgaria

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100191, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100730, China

  • Novartis Investigative Site

    RECRUITING

    Jena, Thuringia, 07740, Germany

  • Novartis Investigative Site

    RECRUITING

    Mainz, 55131, Germany

  • Novartis Investigative Site

    RECRUITING

    Szeged, 6725, Hungary

  • Novartis Investigative Site

    RECRUITING

    Leiden, South Holland, 2333 CL, Netherlands

  • Novartis Investigative Site

    RECRUITING

    Cluj-Napoca, Cluj, 400006, Romania

  • Novartis Investigative Site

    RECRUITING

    Bucharest, 011658, Romania

  • Novartis Investigative Site

    RECRUITING

    Santiago Compostela, A Coruna, 15706, Spain

  • Novartis Investigative Site

    RECRUITING

    Barcelona, 08035, Spain

Conditions

Explore the condition pages connected to this study.